Featuring contributions from leading analysts, professional representatives and patient groups, the event combined the
experience and views of Merck Consumer Health’s senior management team with external perspectives on the major pressures and influences facing the industry.
Highlights
• Consumer Health division hosts top level debate on key aspects of the industry
• Speakers and delegates discuss whether sector is undergoing evolutionary change or a revolutionary shift in behaviors
• Third – quarter figures illustrate continuing success of division with solid year-on-year growth reported
Commenting on today’s event and the publication of the third – quarter results earlier this month Uta Kemmerich – Keil , Chief Executive Officer and President of Consumer Health, said: "Today’s debate is an important milestone for Merck’s Consumer Health division, as we become increasingly important players in the OTC sector .
We hope that by bringing togethe r leading stakeholders from the worlds of business, pharmacy and patient organizations, more clarity will emerge about the key pressures and opportunities that lie ahead for our sector. In light of our positive business results in the third quarter and thr oughout the entire year, these influences are ever more important for mapping out a successful path ahead for our company and for the sector."